{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:54Z","timestamp":1792788114392,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82203323"],"award-info":[{"award-number":["82203323"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82574152"],"award-info":[{"award-number":["82574152"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82472914"],"award-info":[{"award-number":["82472914"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Sanming Project of Medicine in Shenzhen","award":["SZSM202311019"],"award-info":[{"award-number":["SZSM202311019"]}]},{"name":"Shanghai Key Discipline of Public Health Grants Award","award":["GWVI-11.1-20"],"award-info":[{"award-number":["GWVI-11.1-20"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0523300"],"award-info":[{"award-number":["2024ZD0523300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04415-y","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:44:32Z","timestamp":1783669472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging mass cytometry reveals novel cellular neighborhoods for predicting the prognosis of nonalcoholic fatty liver disease-associated hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Bowen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"3","key":"4415_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"4415_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4415_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10290","key":"4415_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"2","key":"4415_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","volume":"76","author":"F FOERSTER","year":"2022","unstructured":"FOERSTER F, GAIRING S J, M\u00fcLLER L, GALLE PR. NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options [J]. J Hepatol. 2022;76(2):446\u201357.","journal-title":"J Hepatol"},{"issue":"6","key":"4415_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2004","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2004;62(6):1723\u201330.","journal-title":"Hepatology"},{"issue":"7796","key":"4415_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","volume":"578","author":"HW Jackson","year":"2020","unstructured":"Jackson HW, Fischer JR, Zanotelli VRT, Ali HR, Mechera R, Soysal SD, et al. The single-cell pathology landscape of breast cancer. Nature. 2020;578(7796):615\u201320.","journal-title":"Nature"},{"issue":"8","key":"4415_CR8","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1194\/jlr.M004515","volume":"51","author":"L CHANG B H, LI","year":"2010","unstructured":"CHANG B H, LI L, SAHA P. Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice [J]. J Lipid Res. 2010;51(8):2132\u201342.","journal-title":"J Lipid Res"},{"issue":"1","key":"4415_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12885-018-4435-1","volume":"18","author":"M Zhang","year":"2018","unstructured":"Zhang M, Pang HJ, Zhao W, Li YF, Yan LX, Dong ZY, et al. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma. BMC Cancer. 2018;18(1):511.","journal-title":"BMC Cancer"},{"key":"4415_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.155115","volume":"128","author":"J Pessoa","year":"2022","unstructured":"Pessoa J, Teixeira J. Cytoskeleton alterations in non-alcoholic fatty liver disease. Metabolism. 2022;128:155115.","journal-title":"Metabolism"},{"key":"4415_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","volume":"40","author":"SM Downs-Canner","year":"2022","unstructured":"Downs-Canner SM, Meier J, Vincent BG, Serody JS. B cell function in the tumor microenvironment. Annu Rev Immunol. 2022;40:169\u201393.","journal-title":"Annu Rev Immunol"},{"key":"4415_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216210","volume":"565","author":"H He","year":"2023","unstructured":"He H, Sugiyama A, Snyder NW, Teneche MG, Liu X, Maner-Smith KM, et al. Acyl-CoA thioesterase 12 suppresses YAP-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis. Cancer Lett. 2023;565:216210.","journal-title":"Cancer Lett"},{"issue":"5","key":"4415_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","volume":"182","author":"CM SCH\u00fcRCH","year":"2020","unstructured":"SCH\u00fcRCH CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, et al. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell. 2020;182(5):1341-59.e19.","journal-title":"Cell"},{"issue":"7948","key":"4415_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","volume":"614","author":"E Karimi","year":"2023","unstructured":"Karimi E, Yu MW, Maritan SM, Perus LJM, Rezanejad M, Sorin M, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours. Nature. 2023;614(7948):555\u201363.","journal-title":"Nature"},{"issue":"3","key":"4415_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","volume":"73","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194\u20138.","journal-title":"Hepatology"},{"issue":"11","key":"4415_CR16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/biomedicines9111524","volume":"9","author":"P Dongiovanni","year":"2021","unstructured":"Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL. Genetics, immunity and nutrition boost the switching from NASH to HCC. Biomedicines. 2021;9(11):1524. https:\/\/doi.org\/10.3390\/biomedicines9111524","journal-title":"Biomedicines"},{"issue":"3","key":"4415_CR17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.29904","volume":"68","author":"Y Kurebayashi","year":"2018","unstructured":"Kurebayashi Y, Ojima H, Tsujikawa H, Kubota N, Maehara J, Abe Y, et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology. 2018;68(3):1025\u201341.","journal-title":"Hepatology"},{"issue":"8","key":"4415_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro B, Sarobe P, HERV\u00e1S-STUBBS S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(8):525\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4415_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS, Cheng AL, Mathurin P, Edeline J, et al. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2022;23(1):77\u201390.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4415_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1200\/JCO.19.01307","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn RS, Ryoo BY, Merle P, Kudo M, Bouattour M, Lim HY, et al. Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial. J Clin Oncol. 2020;38(3):193\u2013202.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4415_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","volume":"20","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Willoughby CE, Singal AG, Greten TF, HEIKENW\u00e4LDER M, El-Serag HB, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20(8):487\u2013503.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"4415_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103233","volume":"24","author":"Q Su","year":"2021","unstructured":"Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, et al. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience. 2021;24(11):103233.","journal-title":"iScience"},{"issue":"3","key":"4415_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijo.2024.5676","volume":"65","author":"S Li","year":"2024","unstructured":"Li S, Hao L, Li N, Hu X, Yan H, Dai E, et al. Targeting the Hippo\/YAP1 signaling pathway in hepatocellular carcinoma: from mechanisms to therapeutic drugs (Review). Int J Oncol. 2024;65(3):88. https:\/\/doi.org\/10.3892\/ijo.2024.5676","journal-title":"Int J Oncol"},{"issue":"14","key":"4415_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306827","volume":"11","author":"K Li","year":"2024","unstructured":"Li K, Zhang J, Lyu H, Yang J, Wei W, Wang Y, et al. CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation. Adv Sci (Weinh). 2024;11(14):e2306827.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4415_CR25","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1038\/s41467-024-52718-3","volume":"15","author":"J Ye","year":"2024","unstructured":"Ye J, Li F, Hua T, Ma K, Wang J, Zhao Z, et al. Liver mechanosignaling as a natural anti-hepatitis B virus mechanism. Nat Commun. 2024;15(1):8375.","journal-title":"Nat Commun"},{"issue":"9","key":"4415_CR26","first-page":"1324","volume":"42","author":"Y LIU","year":"2022","unstructured":"LIU Y, LIANG J, WANG ZENGW. Changes of YAP activity at the early stage of nonalcoholic steatohepatitis and its spatiotemporal relationship with ductular reaction in mice [J]. J South Med Univ. 2022;42(9):1324\u201334.","journal-title":"J South Med Univ"},{"key":"4415_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2024.08.006","volume":"79","author":"B Yu","year":"2024","unstructured":"Yu B, Ma W. Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis. Cytokine Growth Factor Rev. 2024;79:29\u201338.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4415_CR28","doi-asserted-by":"publisher","first-page":"1098056","DOI":"10.3389\/fimmu.2023.1098056","volume":"14","author":"X WANG","year":"2023","unstructured":"WANG X, WANG Z, LIU B, JIN R, SONG Y, FEI R, CONG X, HUANG R, LI X, YANG J, WEI L, RAO H, LIU F. Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH [J]. Front Immunol. 2023;14:1098056.","journal-title":"Front Immunol"},{"issue":"9","key":"4415_CR29","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/hep4.2001","volume":"6","author":"BK Chung","year":"2022","unstructured":"Chung BK, \u00d8gaard J, Reims HM, Karlsen TH, Melum E. Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. Hepatol Commun. 2022;6(9):2538\u201350.","journal-title":"Hepatol Commun"},{"issue":"6","key":"4415_CR30","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","volume":"75","author":"IOANNOU G N","year":"2021","unstructured":"IOANNOU G N. Epidemiology and risk-stratification of NAFLD-associated HCC [J]. J Hepatol. 2021;75(6):1476\u201384.","journal-title":"J Hepatol"},{"issue":"5","key":"4415_CR31","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, HAGSTR\u00f6M H, Nasr P, Fredrikson M, ST\u00e5L P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"issue":"2","key":"4415_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-97.e10.","journal-title":"Gastroenterology"},{"issue":"6","key":"4415_CR33","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"9","key":"4415_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nmeth.4391","volume":"14","author":"D Schapiro","year":"2017","unstructured":"Schapiro D, Jackson HW, Raghuraman S, Fischer JR, Zanotelli VRT, Schulz D, et al. HistoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017;14(9):873\u20136.","journal-title":"Nat Methods"},{"key":"4415_CR35","first-page":"2579","volume":"9","author":"MAATEN L V D","year":"2008","unstructured":"MAATEN L V D, HINTON G E. Visualizing Data using t-SNE [J]. J Mach Learn Res. 2008;9:2579\u2013605.","journal-title":"J Mach Learn Res"},{"issue":"20","key":"4415_CR36","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1093\/nar\/gkr481","volume":"39","author":"PJ Shepard","year":"2011","unstructured":"Shepard PJ, Choi EA, Busch A, Hertel KJ. Efficient internal exon recognition depends on near equal contributions from the 3\u2019 and 5\u2019 splice sites. Nucleic Acids Res. 2011;39(20):8928\u201337.","journal-title":"Nucleic Acids Res"},{"key":"4415_CR37","doi-asserted-by":"crossref","unstructured":"SHI Q, JIANG S, ZENG Y, YUAN X, ZHANG Y, CHU Q, XUE C, LI L. A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma [J]. Journal of Translational Internal Medicine, 2024, 12(6): 553-68.","DOI":"10.1515\/jtim-2024-0020"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04415-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:30Z","timestamp":1791313290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04415-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4415"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04415-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"332"}}